This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development of an ultrasound-coupled electrical impedance tomography (US-EIT) device for assessing sarcopenia, a condition involving loss of skeletal muscle mass and function. The $275,762 award to Rytek Medical Inc. will be used to design a sonolucent electrode array and housing that integrates with a standard ultrasound probe, enabling quantitative evaluation of muscle health through electrical property imaging. The project aims to demonstrate the device's repeatability and ability to distinguish levels of intramuscular fatty infiltration and inflammation in a feasibility study in pigs. This initial Phase 1 effort will position the company for potential Phase 2 funding to conduct a clinical trial assessing sarcopenia in breast cancer patients and prepare a regulatory submission to the FDA.
Generated 7/16/24, 8:31 AM